SCHEMBL2272949

SCHEMBL2272949

CC(C)(C)OC(=O)c1ccc(Oc2ccccc2)cc1NC(=O)c1cncc(-n2cccc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.41
POLB P06746 2/20 0.39
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
USP36 Q9P275 2/20 0.39
SIRT2 Q8IXJ6 1/20 0.38
SIRT1 Q96EB6 1/20 0.38
SIRT3 Q9NTG7 1/20 0.38
DHODH Q02127 1/20 0.38
SERPINE1 P05121 1/20 0.37
NPC1 O15118 2/20 0.37
TP53 P04637 1/20 0.37
RECQL P46063 1/20 0.37
RAB9A P51151 1/20 0.37
ALDH1A1 P00352 2/20 0.36
PGR P06401 1/20 0.36
KMT2A Q03164 1/20 0.36
NTRK1 P04629 1/20 0.36
PYGM P11217 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2275425 0.89 NPC1 (0.43) NPC1RAB9APGRKMT2ANTRK1
SCHEMBL2274764 0.88 ALDH1A1 (0.47) SERPINE1ALDH1A1PYGM
SCHEMBL2270475 0.87 HDAC1 (0.43) MAPK1POLBTSHRNPSR1HSD17B10
SCHEMBL12118089 0.86 ABL1 (0.44) MAPK1POLBTSHRNPSR1HSD17B10
SCHEMBL14428466 0.83 SIRT2 (0.40) USP36SIRT2SIRT1SIRT3DHODH
SCHEMBL27848594 0.80 BRAF (0.42) TSHRHSD17B10NPC1RAB9AALDH1A1
SCHEMBL2269667 0.79 F10 (0.53) POLBNPSR1SERPINE1TP53ALDH1A1
SCHEMBL2273439 0.79 SERPINE1 (0.46) MAPK1POLBTSHRHSD17B10SERPINE1
SCHEMBL12395652 0.78 ACLY (0.41) NPSR1DHODHSERPINE1ALDH1A1KMT2A
SCHEMBL2269139 0.78 CYP2C9 (0.47) MAPK1HSD17B10SERPINE1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 MAPK1 168/4885POLB 3860/4885TSHR 3951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.